The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
Twist Bioscience secures $120M Series D for biotech innovation
Twist Bioscience raises $120M in Series D funding to advance its synthetic biology company manufacturing dna sequences and accelerate market growth.
Modern Meadow transforms biotech industry with $53M Series B at $400M valuation
Modern Meadow achieves $400M valuation through $53M Series B funding, establishing dominance in the biotech market with innovative biotechnology company producing lab-grown leather and meat.
NeuroPharma raises $190M Series B in September 2025 funding round
NeuroPharma secures $190M in Series B funding in September 2025, reaching $1.6B valuation to advance its neurological drug discovery using ai and machine learning.
BioSynth Labs raises $380M Series B in September 2025 funding round
BioSynth Labs secures $380M in Series B funding in September 2025, reaching $3.2B valuation to advance its synthetic biology platform for sustainable chemical manufacturing.
NanoMedicine Labs Raises $460M Series C to Transform Healthcare
NanoMedicine Labs secures $460M in Series C funding at $5.8B valuation to advance phase iii clinical trials, scale manufacturing capabilities, and expand pipeline to rare diseases.
BioAge Therapeutics Raises $350M Series C to Transform Healthcare
BioAge Therapeutics secures $350M in Series C funding at $4.3B valuation to advance anti-aging drug trials, expand research into age-related diseases, and scale manufacturing for clinical studies.
Showing 6 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.